New Key Statistics Module, Z-Score and F-Score
NAS:ABCL Key Ratios
| Market Cap $ M | 3,707.10 |
| Enterprise Value $ M | 3,302.61 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 3.92 |
| Price/Sales | 51.96 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 66.00 |
| EPS (TTM) $ | -0.54 |
| Beneish M-Score | -2.26 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -15.66 |
| EV-to-EBITDA | -18.52 |
| PEG | -- |
| Shares Outstanding M | 324.05 |
| Net Margin (%) | -248.83 |
| Operating Margin % | -318.74 |
| Pre-tax Margin (%) | -297.36 |
| Quick Ratio | 12.63 |
| Current Ratio | 12.77 |
| ROA % (ttm) | -12.23 |
| ROE % (ttm) | -17.25 |
| ROIC % (ttm) | -22.36 |
| Dividend Yield % | -- |
| Altman Z-Score | 5.39 |
ABCL Number of Guru Trades
ABCL Volume of Guru Trades
Gurus Latest Trades with NAS:ABCL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ABCL is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
AbCellera Biologics Inc Insider Transactions
No Available Data
News about NAS:ABCL
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers